Population
Patients with schizophrenia
Design
Review
Authors
Loading...
May prompt integrated CV risk screening in schizophrenia; leaves open targeted prevention trials.
Cardiovascular disease in schizophrenia is multifactorial, involving genetics, metabolic syndrome, and antipsychotic side effects, necessitating multidisciplinary screening and management.
Emül et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: